InvestorsObserver
×
News Home

Should You Add Bicycle Therapeutics PLC (BCYC) Stock to Your Portfolio Monday?

Monday, March 18, 2024 12:03 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Add Bicycle Therapeutics PLC (BCYC) Stock to Your Portfolio Monday?

A rating of 85 puts Bicycle Therapeutics PLC (BCYC) near the top of the Healthcare sector according to InvestorsObserver. Bicycle Therapeutics PLC's score of 85 means that it ranks higher than 85% of stocks in the sector. In addition, its overall score of 51 ranks it higher than 51% of all stocks.

Overall Score - 51
BCYC has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on BCYC!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 51 would rank higher than 51 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Bicycle Therapeutics PLC Stock Today?

Bicycle Therapeutics PLC (BCYC) stock is lower by -0.21% while the S&P 500 is up 0.86% as of 11:42 AM on Monday, Mar 18. BCYC is down -$0.05 from the previous closing price of $23.76 on volume of 44,787 shares. Over the past year the S&P 500 has gained 30.61% while BCYC is up 11.31%. BCYC lost -$5.08 per share the over the last 12 months. Click Here to get the full Stock Report for Bicycle Therapeutics PLC stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App